Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer

This publication has 22 references indexed in Scilit:

• High‐dose epirubicin and r‐met‐hu G‐CSF (Filgrastim) in the treatment of patients with advanced breast cancer: A hellenic cooperative oncology group study
  Medical and Pediatric Oncology, 1995
• Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial.
  Journal of Clinical Oncology, 1993
• Dose-intensive treatment of breast cancer supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)
  Breast Cancer Research and Treatment, 1991
• Effects of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Myelosuppression induced by Multiple Cycles of High-Dose Chemotherapy in Patients With Advanced Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• High-Dose 4′-Epiadriamycin for Treatment of Breast Cancer Refractory to Standard Dose Anthracycline Chemotherapy: Achievement of Second Responses
  Oncology, 1990
• Advanced Breast Cancer: A randomised trial of epidoxorubicin at two different dosages and two administration systems
  Acta Oncologica, 1989
• A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
  Journal of Clinical Oncology, 1988
• A phase I-II study of intensive-dose adriamycin for advanced breast cancer.
  Journal of Clinical Oncology, 1987
• New anthracycline analogs in advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1986
• Reporting results of cancer treatment
  Cancer, 1981